OCT 15, 2026 · JOURNAL ARTICLE
Nanoparticle-Based Oral Delivery of Capecitabine: In Vitro Cytotoxicity and Pharmacokinetic Evaluation in HepG2 and HT-29 Cell Lines
Xenobiotica
Present study aims to develop and assess a capecitabine-loaded nanoparticle formulation (C18) for improved oral bioavailability and targeted anticancer activity.Capecitabine nanopa